miR-532-3p is downregulated in metastatic PCa tissues and was shown to act as a bone metastasis suppressor by inhibiting NF-κB activation through TNF receptor-associated factor 1 (TRAF1), TRAF2, and TRAF3 [108]. Here, TRAF1 is linked to posterior cortical atrophy.